44
Participants
Start Date
May 1, 2019
Primary Completion Date
January 28, 2025
Study Completion Date
December 31, 2026
dasiglucagon
Glucagon analog
Children's Hospital of Colorado, Aurora
Children's Hospital of Philadelphia, Philadelphia
Otto von Guericke University Magdeburg, Department of Pediatrics, Magdeburg
University Hospital Düsseldorf, Department of Pediatrics, Düsseldorf
Cook Children's Medical Center, Fort Worth
Hadassah Medical Center, Jerusalem
NHS Greater Glasgow and Clyde, Glasgow
Alder Hey Children's Hospital NHS Foundation Trust, Liverpool
Great Osmond Street Hospital for Children NHS Foundation Trust, London
Central Manchester University Hospital NHS Foundation Trust, Manchester
Lead Sponsor
Zealand Pharma
INDUSTRY